About GalChimia

GalChimia will be in Basel
December 4, 2014

GalChimia will be in Basel Area for 4 days in December To arrange a meeting during our instance, please contact Ms. Julie…

Read More
GalChimia will be in Belgium for a 3 days Business Trip and the MedChem 2014 day
November 19, 2014

GalChimia will be in Belgium 3 days next week and will attend MedChem 2014, this year the conference is about “New…

Read More
GalChimia has recently obtained the accreditation for Crédit d’Impôt Recherche (CIR)
November 12, 2014

Considered nowadays as the best tax incentive system for research in Europe, the CIR is a tax tool, that works as…

Read More
GalChimia licenses production process for two promising products: Eltrombopag Olamine and Prasugrel Hydrochloride
October 15, 2014

Over the years, GalChimia has become the leading synthetic organic chemistry CRO in Spain. Recently, the company decided to invest resources…

Read More
Biopharma Outsourcing B4B-Connection Toulouse (France) October 21- 22, 2014
September 26, 2014

GalChimia will attend Biopharma Outsourcing B4B-Connection. Contact us to arrange a meeting during the show . We will be delighted to…

Read More
BioSpain 2014, Sept 24-26, Santiago de Compostela (Spain)
July 21, 2014

GalChimiApplus will attend as exhibitor to this event. Contact us to arrange a meeting during the show or visit us at…

Read More
RICT 2014, July 2nd-4th, Rouen (France)
June 9, 2014

GalChimia attended the 50th anniversary of the International Conference on Medicinal Chemistry (RICT). The theme of the…

Read More
Deltamethrin isomers
June 9, 2014

Deltamethrin is one of the most popular insecticides in the world. A member of one of the safest classes of pesticides,…

Read More
R&D Work: Phenethylamines
December 1, 2011

Selective Copper-Promoted Cross-Coupling Reaction of Anilines and Alkylboranes This year we have worked hard on several aspects of the Copper mediated…

Read More
GalChimia Goes Continuous
November 1, 2011

Flow Chemistry New year, new tricks. In a previous issue of our newsletter we have talked about one of the latest…

Read More